26
total announcements
SURAKSHA.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 20 Oct 2026
Market Cap
₹1,552 Cr
P/E (TTM)
43.3
P/E (Forward)
30.4
EPS (TTM)
₹6.88
52W Low
₹224.10
52W High
₹360.00
Dividend Yield
0.16%
Price / Book
6.3
Debt / Equity
53.5
Revenue (TTM)
₹325 Cr
Gross Margin
88.41%
Operating Margin
21.80%
Suraksha Diagnostic Limited
Suraksha Diagnostic Limited has informed the Exchange regarding the appointment of Mr. Dinesh Gupta as Chief Financial Officer of the company with effect from August 24, 2026. The company has also approved the unaudited financial results for the quarter ended June 30, 2026, and the same is enclosed along with the Limited Review Report issued by the Statutory Auditors of the Company.
Suraksha Diagnostic Limited
Suraksha Diagnostic Limited has announced its unaudited financial results for the quarter ended June 30, 2026, and has also approved the appointment of Mr. Dinesh Gupta as the Chief Financial Officer, effective from August 24, 2026. The company has also fixed September 15, 2026, as the record date for determining the entitlement of shareholders to receive dividend for the financial year ended March 31, 2026.
Suraksha Diagnostic Limited
Suraksha Diagnostic Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, and approved the appointment of a new Chief Financial Officer.
Suraksha Diagnostic Limited
Suraksha Diagnostic Limited has postponed its 21st Annual General Meeting due to unavoidable circumstances. The revised date, time, and venue will be decided in due course and informed to the stock exchanges and shareholders accordingly.
Suraksha Diagnostic Limited
Suraksha Diagnostic Limited will host a conference call for analysts and investors to discuss their Q1 FY27 results on Thursday, 13th August 2026, at 11:30 AM IST.
Suraksha Diagnostic Limited
Suraksha Diagnostic Limited has received a certificate under SEBI (Depositories and Participants) Regulations, 2018, from its registrar and share transfer agent, KFin Technologies Limited, for the quarter ended June 30, 2026, confirming the details of securities dematerialized or rematerialized during the period.